RPAM
SWAV

Rhenman & Partners Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-64,000
Closed -$20.8M 97
2024
Q1
$20.8M Sell
64,000
-76,000
-54% -$24.7M 1.98% 19
2023
Q4
$26.7M Buy
140,000
+59,000
+73% +$11.2M 2.67% 9
2023
Q3
$16.1M Buy
81,000
+25,000
+45% +$4.98M 1.74% 25
2023
Q2
$16M Sell
56,000
-11,000
-16% -$3.14M 1.68% 27
2023
Q1
$14.3M Buy
67,000
+20,000
+43% +$4.28M 1.58% 25
2022
Q4
$9.66M Buy
47,000
+27,000
+135% +$5.55M 1.01% 38
2022
Q3
$5.86M Sell
20,000
-50,978
-72% -$14.9M 0.61% 53
2022
Q2
$13.6M Buy
70,978
+16,178
+30% +$3.09M 1.54% 24
2022
Q1
$11.4M Buy
54,800
+20,800
+61% +$4.31M 1.12% 37
2021
Q4
$6.11M Hold
34,000
0.41% 63
2021
Q3
$7M Buy
34,000
+10
+0% +$2.06K 0.49% 61
2021
Q2
$6.45M Sell
33,990
-16,010
-32% -$3.04M 0.44% 73
2021
Q1
$6.51M Sell
50,000
-10,000
-17% -$1.3M 0.45% 62
2020
Q4
$6.22M Hold
60,000
0.51% 60
2020
Q3
$4.55M Hold
60,000
0.4% 66
2020
Q2
$2.84M Buy
+60,000
New +$2.84M 0.31% 76